BPO bioprospect limited

sla cousin in trading halt

  1. 5,754 Posts.
    lightbulb Created with Sketch. 322
    Trading Halt Request Solagran Limited (Company) hereby requests a trading halt pursuant to ASX listing rule 17.1 pending an announcement. The announcement relates to the status of the pharmaceutical wholesale licence for the Company's Russian subsidiary, Solagran Son. The announcement will be released to the market prior to the commencement of trading on Friday February 5 2010 upon which the trading halt will cease. The Company is not aware of any reason why the trading halt should not be granted.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.